CORONA Remedies Limited (CORONA) — corporate announcements

All
Important
Financial Update
Fund Raise
Board Meeting
Dividend/Bonus
JV/Acquisition
Investor Meet
Insider Trade
Pledging
Others

Download our app

Get the best experience on mobile

Join 5K+ users on Alpha Tribe

CORONA Remedies Limited

$CORONA

Unknown

20-08-2026 | 05:20 pm

Corona Remedies Limited officials will attend an investor conference organized by Phillip Capital PCG Group in Ahmedabad. Discussions will cover publicly available information only.

PDF

10-08-2026 | 05:57 pm

CORONA Remedies Limited held an earnings conference call to discuss the financial results for the first quarter of FY27. Management provided an overview of the company's performance, strategic initiatives, and market outlook. Following the presentation, analysts posed questions regarding various aspects of the business.

PDF

10-08-2026 | 11:25 am

Company officials will attend investor conferences organized by Emkay Global and Equirus. These will be in-person group and one-on-one meetings in Mumbai, discussing publicly available information.

PDF

07-08-2026 | 03:53 pm

CORONA Remedies board met and approved Q1 financial results. Revenue grew 21.9% YoY to ₹422.4 Cr, PAT up 30.1% YoY to ₹60.1 Cr. The company inaugurated an EU-GMP approved Female Hormone Facility and integrated the Wokadine brand.

PDF

03-08-2026 | 04:24 pm

Corona Remedies Limited has uploaded the audio recording of its Q1 FY27 earnings conference call for analysts and investors. The call discussed the company's financial results for the quarter ended June 30, 2026.

PDF

Download our app

CORONA Remedies Limited

CORONA Remedies Limited

Analysts/Institutional Investor Meet/Con. Call Updates

CORONA Remedies Limited

Analysts/Institutional Investor Meet/Con. Call Updates

CORONA Remedies Limited

Analysts/Institutional Investor Meet/Con. Call Updates

CORONA Remedies Limited

Updates

CORONA Remedies Limited

Analysts/Institutional Investor Meet/Con. Call Updates